• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Citrus Support for the Blood Glucose-Immune System Connection

    A Glance At The Eye Health Market

    The Value of Vitamin D Testing

    A Growing Need for Mineral Supplementation

    More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Ingredient Manufacturers Discuss the E-Sports Market

    Euromonitor Names Top Ten Trends for 2021

    Study Highlights Differences Between EPA's and DHA's Effect on Sleep

    BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise

    Qualitas Health/iwi Raises $10 Million in Investment Round
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Ingredient Manufacturers Discuss the E-Sports Market

    Study Highlights Differences Between EPA's and DHA's Effect on Sleep

    More Than Just A Trend: Supplements Embedded in Consumer Health Regimens

    An Interview with Michael Bentley, President, SierraSIl

    Themes For The Long Haul
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Ingredient Manufacturers Discuss the E-Sports Market

    Euromonitor Names Top Ten Trends for 2021

    Study Highlights Differences Between EPA's and DHA's Effect on Sleep

    The Value of Vitamin D Testing

    A Growing Need for Mineral Supplementation
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Ingredient Manufacturers Discuss the E-Sports Market

    Euromonitor Names Top Ten Trends for 2021

    Study Highlights Differences Between EPA's and DHA's Effect on Sleep

    Themes For The Long Haul

    ‘Follow the Science’ Often Misses the Mark with Nutrition
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Verdure Sciences

    Chenland Nutritionals Inc.

    Indena USA, Inc.

    Sabinsa Corporation

    Bioenergy Life Science, Inc. (BLS)
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    KLK OLEO - Davos Life Science

    AIDP

    Bioenergy Life Science, Inc. (BLS)

    Verdure Sciences

    Chenland Nutritionals Inc.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Health E-Insights

    An Interview with Manoj Dadlani, CEO, CosmosID

    Dadlani is CEO of the Maryland-based provider of industry-leading solutions for unlocking the microbiome.

    An Interview with Manoj Dadlani, CEO, CosmosID
    Related CONTENT
    • CBD Talk Podcast Host Dawn Peacock: Slashing Stigmas & Countering Misinformation
    • An Interview with Ned Becker of Columbia Nutritional
    • Cannovia: Clearing Up CBD Market Confusion
    • Emerald Bioceuticals: Broad Support for the Endocannabinoid System
    • Balanced Health Botanicals: Fueling The CBD Movement
    By Sheldon Baker10.07.19
    Previously, Dadlani served as a partner at Applied Value Group, a management consulting and investment firm, and was co-founder and CEO at Rasa Industries, Ltd., a leading beverage manufacturing company. Dadlani has substantial experience in strategy, mergers and acquisitions, supply chain management, product development, marketing and business development. He received his bachelors and master’s degrees in biological engineering from Cornell University.

      
    Health E-Insights: CosmosID provides Next-Generation Sequencing (NGS) and Bioinformatics solutions. Please explain.
     
    Dadlani: CosmosID is a microbial genomics company at its core and we're the industry leaders in rapid, high resolution identification and characterization of microorganisms. We offer software as well as end-to-end sequencing and analysis services optimized for pharmaceutical, nutritional R&D, food safety, and molecular diagnostics. We leverage over 10 years of experience and expertise in the field of microbiome analysis and support industry and academia across the entire NGS workflow, from study design to sample collection, extraction, library preparation, sequencing, bioinformatics, publication and regulatory support. What ultimately differentiates CosmosID is its bioinformatics platform. We've been continuously curating the world's largest reference database of microbial genomes as well as antimicrobial resistance and virulence data and our algorithms have been independently validated to quantitatively identify bacteria, viruses, fungi, and protists down to strain-level, with industry-leading sensitivity and precision. While conventional data analysis methods can take many hours per sample our platform returns results within minutes and directly into a user-friendly cloud application with robust interactive visualization tools. You can test out our platform by creating a free account at app.cosmosid.com.
     
    Health E-Insights: Your company’s origin is an interesting one.
     
    Dadlani: It certainly is. The company was founded in 2008 by Professor Rita Colwell; a world-renowned microbiologist and one of the foremost experts in environmental metagenomics. Her resume includes being an author of over 800 publications, 19 books; and Rita has received 64 honorary degrees. Outside of the world of research, Rita is mostly known in the public eye for having been the first female head of the National Science Foundation from 1998 to 2004, under the Clinton and Bush administrations. During her time, she and a team of experts were tasked with tracking the source of the anthrax outbreak in 2001. Tracking such outbreaks at that time was exceedingly difficult, given the tools at one’s disposal. This inspired Rita to develop a bioinformatics platform that could identify organisms down to the strain-level within complex microbiota samples to not only address future bio-threats but impact clinical microbiology and health-relevant industries and do so in a rapid and accurate manner. This was all based on an emerging technology at the time, one which we use regularly today, Whole-Genome Sequencing. Ten years later, the platform Rita had envisioned is the core of the CosmosID technology. It's commercialized and currently being used by hundreds of scientists around the world.
     
    Health E-Insights: Do your services focus on supplements as well as pharmaceuticals?
     
    Dadlani: Absolutely. We see a lot of crossover between these two industries in the context of microbiome R&D. Both industries are interested in the same questions and sample types when it comes to understanding the impact of nutrition, supplements, or novel drugs on our health and the gut, skin, oral, or vaginal microbiome. We just see it as two sides of the same coin. The difference is ultimately how the research will be applied and in what regulatory environment. There have been tremendous strides in the world of microbial genomics in the last few years and given the decreasing cost in NGS, there's been an explosion of interest and research being done in R&D for supplements and nutraceuticals. The exact application of that research looks very different depending on which company you speak to, but an example would be to discover novel nutritional supplements that modulate the microbiome to achieve a desired effect on health and wellness. This can be in the form of a pre- or probiotic, which are popular and obvious choices, but also through other extracts and natural ingredients. Another interesting application is to go back and look on your shelf of already existing products and ingredients and run a retrospective study on how they may be impacting the microbiome of consumers. Some products may be impacting the microbiome positively and you don't even know it. Additionally, this same technology is used in quality control of the strains that go into a probiotic. Using NGS, we can validate and quantify whether the right strains are actually in the products that consumers are buying and ensure that the labeling claims are correct.
     
    Health E-Insights: What if any are the emerging trends in the microbiome category?
     
    Dadlani: There are quite a few increasingly popular and emerging research areas in the microbiome such as sports nutrition and infant health, but one that's arguably the most exciting is the gut-brain axis. There's a tremendous amount of research emerging to suggest that through interactions with the host immune system or via various neurotransmitter-like metabolites, the microbiome could be having a major impact on mental health which means, if harnessed correctly, we could see a new wave of probiotic products developed specifically for conditions like stress, mood, and sleep disorders. We still have a way to go in terms of understanding which bugs impact our mood, for example, and how, but it's exciting to think that consumers may soon have more options when it comes to improving their mental health and well-being before having to take prescription medication.
     
    Health E-Insights: Will advances in technology enhance what your company does?
     
    Dadlani: Without a doubt. Our company leverages technologies developed NGS instrument providers such as Illumina and ThermoFisher and so as we start to see improvements and efficiencies introduced to the NGS workflow by emerging kits and products, we plan to continue improving the quality of data we provide to our customers, but do so in a more efficient and cost-effective manner. Currently, over 90% of the microbiome space relies on short-reading sequencing by instrument providers. But there are many in the industry that believe that long-read sequencing is the future, and for good reasons. Our bioinformatics platform is already compatible with this new data type and we're keeping a close eye on long-read sequencing as costs decrease so that we can leverage the CosmosID platform in other innovative ways.
     
    Health E-Insights: What new competition do you envision within the next 3-5 years?
     
    Dadlani: I’m incredibly excited about the nutraceutical space over the next five years. I feel that consumers are taking a much closer look at their how supplements can improve their well-being and are spending serious dollars on products that they feel are beneficial. My prediction in the space is that as consumers become more educated the supplement companies that will win are those who have invested in studies to show stronger scientific data to back their claims. Additionally, lifestyle diagnostic tests, will also guide consumers in personalization of their nutraceutical choices. From a competitive landscape, I think we’ll see companies that embrace transparency in their trials, as well as embrace personalization to lead the pack.
     
    Health E-Insights: What excites you most about what you do?
     
    Dadlani: We’re fortunate to be part of a game-changing technological revolution in microbiology. Today, using DNA sequencing, we’re able to view microorganisms that previously could not be cultured or studied and understand their effects on improving human health. As a biological engineer, being able to translate this new knowledge into businesses and products that can aid in improving general health and possibly curing diseases is what keeps me excited every day.
     
    Health E-Insights: Can you name a person who has had a tremendous impact on you as a leader?
     
    Dadlani: It would be hard for me to just name one person here, so I’ll take the liberty to name two. The first one is Dr. Dan Luo, my research advisor at Cornell University in the department of Biological and Environmental Engineering. He taught me that you can apply biology to solve engineering problems in ways that do not apply to traditional biology paradigms. An example of his work is using DNA as a synthetic material to deliver a drug and evade traditional human immune responses, rather than as a traditional vector of genetic code. Overall, he has taught me to push the boundaries in problem solving and think out of the box to find solutions. The other person that has impacted me significantly as a leader is Bruce Grant, the founder and chairman of the Applied Value Group, the organization I joined after graduating from Cornell. The two fundamental principles that Bruce always taught are to make data driven decisions that allow us to always be fact-based and how to efficiently grow an organization through the key principles of lean growth: focus, simplicity, and speed.

      
    Sheldon Baker is CEO of the Baker Dillon Group LLC and has created numerous nutraceutical brand marketing communications and public relations campaigns for many well-known supplement and food industry companies. For Health E-Insights interview consideration or brand marketing consulting, contact him at SBaker@BakerDillon.com.
     
    Related Searches
    • supply chain
    • genome sequencing
    • Research
    • labeling
    Related Knowledge Center
    • Digestive Health
    • Probiotics & Prebiotics
    • Healthcare Trends
    Suggested For You
    CBD Talk Podcast Host Dawn Peacock: Slashing Stigmas & Countering Misinformation CBD Talk Podcast Host Dawn Peacock: Slashing Stigmas & Countering Misinformation
    An Interview with Ned Becker of Columbia Nutritional An Interview with Ned Becker of Columbia Nutritional
    Cannovia: Clearing Up CBD Market Confusion Cannovia: Clearing Up CBD Market Confusion
    Emerald Bioceuticals: Broad Support for the Endocannabinoid System Emerald Bioceuticals: Broad Support for the Endocannabinoid System
    Balanced Health Botanicals: Fueling The CBD Movement Balanced Health Botanicals: Fueling The CBD Movement
    Mile High Labs: Stephen Mueller & The Mile High Monster Mile High Labs: Stephen Mueller & The Mile High Monster
    An Interview with Tracey Seipel, ND, of the Seipel Group An Interview with Tracey Seipel, ND, of the Seipel Group
    Area Code 420 Has Arrived Area Code 420 Has Arrived
    An Interview with Christopher Detzel of Entera Health An Interview with Christopher Detzel of Entera Health
    An Interview with Ohad Cohen of Gadot Biochemical Industries An Interview with Ohad Cohen of Gadot Biochemical Industries

    Related Health E-Insights

    • Dietary Supplements | Healthcare Trends | Minerals | Sports Nutrition
      An Interview with Michael Bentley, President, SierraSIl

      An Interview with Michael Bentley, President, SierraSIl

      Canadian natural products company SierraSil Health Inc is on a mission to help one million plus people feel empowered to lead natural, healthy, active lives.
      By Sheldon Baker 01.19.21

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | World Markets
      An Interview with Amit Srivastava, Chief Catalyst, Responsible Nutrition Business, Nutrify India

      An Interview with Amit Srivastava, Chief Catalyst, Responsible Nutrition Business, Nutrify India

      Srivastava is a trendsetter in the nutraceutical industry from innovation to regulatory and government, and to building a start-up ecosystem.
      By Sheldon Baker 12.04.20

    • Dietary Supplements | Healthcare Trends | Infant & Children's Health
      An Interview with Angela Stephens, CEO, RE-Focus, The Creative Office & A. Stephens & Associates

      An Interview with Angela Stephens, CEO, RE-Focus, The Creative Office & A. Stephens & Associates

      Her boutique executive search firm is focused on the pharmaceutical, biotech, medical device, consumer, food, and nutrition industries.
      By Sheldon Baker 11.09.20


    • Delivery & Dosage Technologies | Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Vitamins
      An Interview with Vishal Shah, Director of Nutriventia (a brand of Inventia Healthcare Limited)

      An Interview with Vishal Shah, Director of Nutriventia (a brand of Inventia Healthcare Limited)

      Shah is passionate about solving ingredient problems by applying technology platforms that make it easier to deliver and enhance natural products.
      By Sheldon Baker 10.01.20

    • Delivery & Dosage Technologies | Dietary Supplements | Immune Function
      An Interview with Christopher Shade, PhD, Founder & CEO Quicksilver Scientific

      An Interview with Christopher Shade, PhD, Founder & CEO Quicksilver Scientific

      Shade's current focus is on the development of cutting-edge, lipid-based delivery systems for nutraceuticals.
      By Sheldon Baker 09.08.20

    • Dietary Supplements
      An Interview with Lynda Doyle, President & CEO, Avant Nutrition

      An Interview with Lynda Doyle, President & CEO, Avant Nutrition

      A recognized strategic senior executive in the nutrition industry, Doyle has a passion for doing what is right for the business, its people, and the community.
      By Sheldon Baker 07.15.20


    • Healthcare Trends | Sports Nutrition
      An Interview with Jonathan Thompson, General Manager, Isopure Company

      An Interview with Jonathan Thompson, General Manager, Isopure Company

      He has held various leadership roles throughout the food and supplement industry.
      By Sheldon Baker 06.02.20

    • Dietary Supplements | Healthcare Trends | Proteins, Peptides, Amino Acids
      An Interview with Douglas Wyatt, Founder, Sovereign Laboratories

      An Interview with Douglas Wyatt, Founder, Sovereign Laboratories

      Recognized as a leading expert in colostrum, is credited with reintroducing bovine colostrum into human use in the 21st century.
      By Sheldon Baker 05.01.20

    • Contract Manufacturing | Dietary Supplements
      An Interview with William Solomon, COO, SternMaid America

      An Interview with William Solomon, COO, SternMaid America

      Solomon is chief operating officer for Aurora, IL-based SternMaid America, the U.S. contract manufacturing business.
      By Sheldon Baker 04.09.20


    • Antioxidants | Dietary Supplements | Eye Health | Healthy Aging | Infant & Children's Health | Minerals | Vitamins
      An Interview with Andreas Wolf, President of Eye Promise

      An Interview with Andreas Wolf, President of Eye Promise

      Business leader driven by personal values of hard work, trust and integrity.
      By Sheldon Baker 11.05.19

    • Contract Manufacturing | Dietary Supplements
      An Interview with Ned Becker of Columbia Nutritional

      An Interview with Ned Becker of Columbia Nutritional

      Over the course of his career, Becker has worked with hundreds of different brands.
      By Sheldon Baker 09.09.19

    • Digestive Health | Immune Function | Probiotics & Prebiotics | Proteins, Peptides, Amino Acids
      An Interview with Christopher Detzel of Entera Health

      An Interview with Christopher Detzel of Entera Health

      Detzel, PhD, is director of research and development; he has led both the non-clinical and clinical research programs since 2016.
      By Sheldon Baker 06.03.19


    • Quality & Safety | Testing
      An Interview with Tony Nguyen of Dyad Labs

      An Interview with Tony Nguyen of Dyad Labs

      VP of corporate relations has over 17 years of experience in the dietary supplement, food and beverage, cosmetic and pharmaceutical industries.
      By Sheldon Baker 04.01.19

    • Antioxidants | Dietary Supplements | Energy | Healthy Aging | Research
      An Interview with Greg Macpherson, CEO of MitoQ Ltd

      An Interview with Greg Macpherson, CEO of MitoQ Ltd

      MitoQ Ltd is a health supplement company that focuses on mitochondrial health with its breakthrough mitochondria-targeted antioxidant called MitoQ.
      By Sheldon Baker 03.01.19

    • Healthcare Trends
      An Interview with Mitchell Stevko of Growth CEO Advisors

      An Interview with Mitchell Stevko of Growth CEO Advisors

      Chief executive of Growth CEO Advisors helps business leaders who are doing good in the world to fund, grow, and exit.
      By Sheldon Baker 12.06.18

    Trending
    • Nutrition Industry Reacts To 2020-2025 Dietary Guidelines For Americans
    • Preliminary Study Suggests Link Between Omega-3s And Lower COVID-19 Death Rates
    • NOW Raises Additional Concerns About Supplements Available On Amazon
    • High-Protein Meal Replacement Improves Exercise Metabolism Compared To Standard Breakfast
    • Seraphina Therapeutics Formulates Dairy Ingredient For Cellular Health
    Breaking News
    • Ingredient Manufacturers Discuss the E-Sports Market
    • Euromonitor Names Top Ten Trends for 2021
    • Study Highlights Differences Between EPA's and DHA's Effect on Sleep
    • BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise
    • Qualitas Health/iwi Raises $10 Million in Investment Round
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2021

    • A Glance At The Eye Health Market
    • Citrus Support for the Blood Glucose-Immune System Connection
    • Modern Snacking: Where Health & Indulgence Converge
    • More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    • A Growing Need for Mineral Supplementation
    • The Value of Vitamin D Testing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ingredient Manufacturers Discuss the E-Sports Market
    Euromonitor Names Top Ten Trends for 2021
    Study Highlights Differences Between EPA's and DHA's Effect on Sleep
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    RSIP Vision Announces Versatile Medical Image Segmentation Tool
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Global Biosciences Co. Selects ValGenesis VLMS
    Eisai Appoints Chief Clinical Officer of Oncology Biz
    Nexelis Acquires GSK Vax Lab in Marburg
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Top Beauty Brands in the World—And Most Loved Fragrances
    P&G Reports Q2 Results
    A Lacquering Technique Makes Very Good Girl by Carolina Herrera Shine
    Happi

    Latest Breaking News From Happi

    Flow Launches Collagen Waters
    Associations Congratulate Biden & Harris
    David Stanko Joins JPMS
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    First Quality Launches Incognito by Prevail
    Essity Launches Reusable Underwear Product
    Honeywell Delivered 225 Million Masks in December
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    DJO Acquires Trilliant Surgical
    FDA Breakthrough Device Designation Granted to Spiderwort's Spinal Cord Technology
    Bioventus Appoints SVP of Operations
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login